Century Sage Scientific Holdings Limited

HKEX:1450.HK

1 (HKD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q22017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q4
Revenue 622.063641.655432.68288.453137.15391.74111.048100.34952.95772.259118.771191.926289.443371.898290.99364.183259.249495.738252.797449.064179.694157.19
Cost of Revenue 301.465326.078188.319153.5382.2860.26182.19662.31935.13658.59283.851148.047211.495261.142206.474260.7179.788340.012177.571306.854128.344108.8
Gross Profit 320.598315.577244.361134.92354.87331.47928.85238.0317.82113.66734.9243.87977.948110.75684.516103.48379.461155.72675.226142.2151.3548.39
Gross Profit Ratio 0.5150.4920.5650.4680.40.3430.260.3790.3370.1890.2940.2290.2690.2980.290.2840.3070.3140.2980.3170.2860.308
Reseach & Development Expenses 0000.02700.17501.9587.865.5449.9989.401.75100.33900.0205.27500
General & Administrative Expenses 81.71285.26388.38358.72449.12333.62142.55156.40123.15886.11722.87926.92545.83852.73740.36640.07145.77636.49341.55838.52224.40615.732
Selling & Marketing Expenses 153.236153.943107.73544.56126.2996.9483.9815.7945.12810.669.26513.10714.56321.97913.49823.0911.59521.52511.04218.4414.9168.339
SG&A 234.948246.039196.118103.37775.42246.69346.53283.96228.28698.83332.14440.03260.40174.71653.86463.16157.37158.01852.656.96239.32224.071
Other Expenses 0-76.24300000000000000000000
Operating Expenses 234.948169.796191.248104.00777.66174.5343.528103.00941.0281.23642.31741.38257.4573.96951.52763.76756.57763.10752.39356.24839.67524.071
Operating Income 85.65145.78148.24334.312-20.549-9.774-17.68-36.75-15.337-73.564-4.7380.74919.67138.51331.77343.64222.88498.10322.83385.83311.67524.319
Operating Income Ratio 0.1380.2270.1110.119-0.15-0.107-0.159-0.366-0.29-1.018-0.040.0040.0680.1040.1090.120.0880.1980.090.1910.0650.155
Total Other Income Expenses Net 11.766-54.464-0.041-10.458-9.3616.851-6.056-16.475-14.264-4.386-8.851-2.862-1.228-4.976-5.108-6.563-2.786-3.403-5.393-1.922-1.44-0.783
Income Before Tax 97.41691.31748.20223.854-29.91-48.498-23.736-70.057-29.601-77.95-13.589-2.11318.44334.76326.66537.07920.09894.717.4483.91110.23523.537
Income Before Tax Ratio 0.1570.1420.1110.083-0.218-0.529-0.214-0.698-0.559-1.079-0.114-0.0110.0640.0930.0920.1020.0780.1910.0690.1870.0570.15
Income Tax Expense 13.60320.5994.94910.250.0853.6030.0931.5840.1173.7830.8880.1032.9473.75.1813.663.4310.3664.72114.5831.8084.098
Net Income 85.07775.28244.1817.796-27.003-40.699-20.916-68.741-28.79-71.891-12.434-2.21614.65529.91221.48433.41916.66884.33412.71969.3288.42719.439
Net Income Ratio 0.1370.1170.1020.062-0.197-0.444-0.188-0.685-0.544-0.995-0.105-0.0120.0510.080.0740.0920.0640.170.050.1540.0470.124
EPS 0.0620.0550.0320.015-0.025-0.038-0.02-0.066-0.028-0.07-0.012-0.0020.0140.0290.0220.0330.0170.0830.0170.0920.0110.026
EPS Diluted 0.0620.0550.0320.015-0.025-0.038-0.02-0.066-0.028-0.07-0.012-0.0020.0140.0290.0220.0330.0170.0850.0170.0920.0110.026
EBITDA 112.27385.81459.42135.616-17.629-7.883-14.632-35.442-9.515-71.7181.0796.05127.64144.12938.17249.33528.204103.88526.63990.58615.25724.43
EBITDA Ratio 0.180.1340.120.123-0.129-0.086-0.132-0.353-0.18-0.9930.0090.0320.0950.1190.1310.1350.1090.210.1050.2020.0850.155